EPICO project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients

被引:13
作者
Zaragoza, Rafael [1 ]
Llinares, Pedro [2 ]
Maseda, Emilio [3 ]
Ferrer, Ricard [4 ]
Rodriguez, Alejandro [5 ]
机构
[1] Hosp Univ Dr Peset, Serv Med Intensiva, Valencia, Spain
[2] Complejo Hosp Univ A Coruna, Unidad Enfermedades Infecciosas, La Coruna, Spain
[3] Hosp Univ La Paz, Serv Anestesiol & Reanimac, Madrid, Spain
[4] Hosp Univ Mutua Terrasa, Serv Med Intensiva, Barcelona, Spain
[5] Hosp Univ Juan XXIII, Serv Med Intensiva, Tarragona, Spain
来源
REVISTA IBEROAMERICANA DE MICOLOGIA | 2013年 / 30卷 / 03期
关键词
Invasive candidiasis; DELPHI technique; Non-neutropenic critically ill patients; Educational project; Recommendations; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; RISK-FACTORS; ANTIMANNAN ANTIBODIES; EPIDEMIOLOGIC TRENDS; ANTIFUNGAL THERAPY; EARLY-DIAGNOSIS; 2009; UPDATE; CANDIDEMIA;
D O I
10.1016/j.riam.2013.05.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Although there has been an improved management of invasive candidiasis in the last decade, controversial issues still remain, especially in the diagnostic and therapeutic approaches. Aims: We sought to identify the core clinical knowledge and to achieve high level agreement recommendations required to care for critically ill adult patients with invasive candidiasis. Methods: A prospective Spanish survey reaching consensus by the DELPHI technique was made. It was anonymously conducted by electronic mail in a first term to 25 national multidisciplinary experts in invasive fungal infections from five national scientific societies, including intensivists, anesthesiologists, microbiologists, pharmacologists and infectious diseases specialists, who answered to 47 questions prepared by a coordination group after a strict review of the literature in the last five years. The educational objectives spanned five categories, including epidemiology, diagnostic tools, prediction rules, and treatment and de-escalation approaches. The level of agreement achieved among the panel experts in each item should exceed 75% to be selected. In a second term, after extracting recommendations from the selected items, a face to face meeting was performed where more than 80 specialists in a second round were invited to validate the preselected recommendations. Results: In the first term, 20 recommendations were preselected (Epidemiology 4, Scores 3, Diagnostic tools 4, Treatment 6 and De-escalation approaches 3). After the second round, the following 12 were validated: (1) Epidemiology (2 recommendations): think about candidiasis in your Intensive Care Unit (ICU) and do not forget that non-Candida albicans-Candida species also exist. (2) Diagnostic tools (4 recommendations): blood cultures should be performed under suspicion every 2-3 days and, if positive, every 3 days until obtaining the first negative result. Obtain sterile fluid and tissue, if possible (direct examination of the sample is important). Use non-culture based methods as microbiological tools, whenever possible. Determination of antifungal susceptibility is mandatory. (3) Scores (1 recommendation): as screening tool, use the Candida Score and determine multicolonization in high risk patients. (4) Treatment (4 recommendations): start early. Choose echinocandins. Withdraw any central venous catheter. Fundoscopy is needed. (5) De-escalation (1 recommendation): only applied when knowing susceptibility determinations and after 3 days of clinical stability. The higher rate of agreement was achieved in the optimization of microbiological tools and the withdrawal of the catheter, whereas the lower rate corresponded to de-escalation therapy and the use of scores. Conclusions: The management of invasive candidiasis in ICU patients requires the application of a broad range of knowledge and skills that we summarize in our recommendations. These recommendations may help to identify the potential patients, standardize their global management and improve their outcomes, based on the DELPHI methodology. This article is also published in Spanish in this issue. It can be found in http://dx.doi.org/10.1016/j.riam.2013.05.005 (c) 2013 Revista lberoamericana de Micologia. Published by Elsevier Espana. S.L. All rights reserved.
引用
收藏
页码:135 / 149
页数:15
相关论文
共 70 条
  • [1] Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease
    Acosta, J.
    Catalan, M.
    del Palacio-Perez-Medel, A.
    Montejo, J. -C.
    De-La-Cruz-Bertolo, J.
    Moragues, M. -D.
    Ponton, J.
    Finkelman, M. A.
    del Palacio, A.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (05) : 721 - 731
  • [2] Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update
    Aguado, Jose Maria
    Ruiz-Camps, Isabel
    Munoz, Patricia
    Mensa, Jose
    Almirante, Benito
    Vazquez, Lourdes
    Rovira, Montserrat
    Martin-Davila, Pilar
    Moreno, Asuncion
    Alvarez-Lerma, Francisco
    Leon, Cristobal
    Madero, Luis
    Ruiz-Contreras, Jesus
    Fortun, Jesus
    Cuenca-Estrella, Manuel
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (05): : 345 - 361
  • [3] Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit:: Candida colonization index, risk factors, treatment and outcome
    Agvald-Ohman, Christina
    Klingspor, Lena
    Hjelmqvist, Hans
    Edlund, Charlotta
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (02) : 145 - 153
  • [4] Comparative evaluation of (1,3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia
    Alam, Fasahat F.
    Mustafa, Abu S.
    Khan, Zia U.
    [J]. BMC INFECTIOUS DISEASES, 2007, 7 (1)
  • [5] Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
    Almirante, B
    Rodríguez, D
    Park, BJ
    Cuenca-Estrella, M
    Planes, AM
    Almela, M
    Mensa, J
    Sanchez, F
    Ayats, J
    Gimenez, M
    Saballs, P
    Fridkin, SK
    Morgan, J
    Rodriguez-Tudela, JL
    Warnock, DW
    Pahissa, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) : 1829 - 1835
  • [6] Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
    Andes, David R.
    Safdar, Nasia
    Baddley, John W.
    Playford, Geoffrey
    Reboli, Annette C.
    Rex, John H.
    Sobel, Jack D.
    Pappas, Peter G.
    Kullberg, Bart Jan
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (08) : 1110 - 1122
  • [7] Epidemiology of invasive candidiasis
    Arendrup, Maiken C.
    [J]. CURRENT OPINION IN CRITICAL CARE, 2010, 16 (05) : 445 - 452
  • [8] Arendrup MC, 2008, CLIN MICROBIOL INFEC, V14, P487
  • [9] Epidemiological trends in nosocomial candidemia in intensive care
    Bassetti, M
    Righi, E
    Costa, A
    Fasce, R
    Molinari, MP
    Rosso, R
    Pallavicini, FB
    Viscoli, C
    [J]. BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [10] A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
    Betts, Robert F.
    Nucci, Marcio
    Talwar, Deepak
    Gareca, Marcelo
    Queiroz-Telles, Flavio
    Bedimo, Roger J.
    Herbrecht, Raoul
    Ruiz-Palacios, Guillermo
    Young, Jo-Anne H.
    Baddley, John W.
    Strohmaier, Kim M.
    Tucker, Kimberly A.
    Taylor, Arlene F.
    Kartsonis, Nicholas A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) : 1676 - 1684